Development and validation of the ADHD Symptom and Side Effect Tracking – Baseline Scale (ASSET-BS): a novel short screening measure for ADHD in clinical populations

CONCLUSION: The scale demonstrated effectiveness in screening for ADHD in a psychiatric outpatient population. Its results may be used to identify patients that may benefit from thorough ADHD diagnostic procedures.

via https://pubmed.ncbi.nlm.nih.gov/37932675/?utm_source=no_user_agent&utm_medium=rss&utm_campaign=None&utm_content=1lqZ3NPYysePVKsoyz66mDSgu4veDGJwnUBS47TBQPoOuNZY5J&fc=None&ff=20231125011008&v=2.17.9.post6+86293ac